A competition enzyme immunoassay for brucellosis diagnosis

Area of Science:

• Veterinary Immunology
• Bacteriology
• Diagnostic Assays

Background:

• Brucellosis remains a significant concern in cattle populations worldwide.
• Accurate detection of Brucella infections is crucial for disease control and eradication programs.
• Current diagnostic methods like the complement fixation test (CFT) have limitations in sensitivity and specificity.

Purpose of the Study:

• To evaluate a novel competitive enzyme immunoassay (cEIA) for detecting Brucella-specific antibodies in cattle sera.
• To compare the diagnostic performance of the cEIA with the established complement fixation test (CFT).
• To assess the cEIA's ability to differentiate between sera from naturally infected and vaccinated cattle.

Main Methods:

• Two distinct monoclonal antibodies (MAbs) conjugated with horseradish peroxidase were employed in a competitive enzyme immunoassay (cEIA).
• The cEIA was performed on a total of 1388 cattle sera, including samples from Brucella-free, infected, and vaccinated animals.
• Results from the cEIA were directly compared against those obtained using the complement fixation test (CFT).

Main Results:

• The cEIA demonstrated higher sensitivity than the CFT, successfully avoiding false-negative results across all tested sera.
• The assay effectively distinguished between antibodies produced due to natural B. abortus infection and those from vaccination.
• No false negatives were observed with the cEIA, indicating superior detection capabilities.

Conclusions:

• The developed competitive enzyme immunoassay (cEIA) is a highly sensitive and specific diagnostic tool for Brucella antibody detection in cattle.
• This MAb-based cEIA offers a significant advancement over the CFT, particularly in differentiating infected from vaccinated animals.
• The cEIA's improved performance supports its potential application in effective Brucellosis surveillance and control strategies.